BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23900072)

  • 1. PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease.
    Pulido R; Stoker AW; Hendriks WJ
    Hum Mol Genet; 2013 Oct; 22(R1):R66-76. PubMed ID: 23900072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Extended Family of Protein Tyrosine Phosphatases.
    Alonso A; Nunes-Xavier CE; Bayón Y; Pulido R
    Methods Mol Biol; 2016; 1447():1-23. PubMed ID: 27514797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic approaches to studying protein tyrosine phosphatases.
    Liang F; Kumar S; Zhang ZY
    Mol Biosyst; 2007 May; 3(5):308-16. PubMed ID: 17460790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast substrate-trapping system for isolating substrates of protein tyrosine phosphatases: Isolation of substrates for protein tyrosine phosphatase receptor type z.
    Fukada M; Kawachi H; Fujikawa A; Noda M
    Methods; 2005 Jan; 35(1):54-63. PubMed ID: 15588986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yeast substrate-trapping system for isolating substrates of protein tyrosine phosphatases.
    Fukada M; Noda M
    Methods Mol Biol; 2007; 365():371-82. PubMed ID: 17200575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of protein tyrosine phosphatases with specificity for the ligand-activated growth hormone receptor.
    Pasquali C; Curchod ML; Wälchli S; Espanel X; Guerrier M; Arigoni F; Strous G; Hooft van Huijsduijnen R
    Mol Endocrinol; 2003 Nov; 17(11):2228-39. PubMed ID: 12907755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional studies of protein tyrosine phosphatases with chemical approaches.
    Zhang ZY
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Dominant-Negative/Substrate Trapping PTP Mutations to Search for PTP Interactors/Substrates.
    Radha V
    Methods Mol Biol; 2016; 1447():243-65. PubMed ID: 27514810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity-based high-throughput determination of PTPs substrate specificity using a phosphopeptide microarray.
    Gao L; Sun H; Yao SQ
    Biopolymers; 2010; 94(6):810-9. PubMed ID: 20725946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
    Burke TR; Zhang ZY
    Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatases in cancer: friends and foes!
    Labbé DP; Hardy S; Tremblay ML
    Prog Mol Biol Transl Sci; 2012; 106():253-306. PubMed ID: 22340721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation.
    Denu JM; Tanner KG
    Biochemistry; 1998 Apr; 37(16):5633-42. PubMed ID: 9548949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine phosphatases: dephosphorylating the epidermal growth factor receptor.
    Tiganis T
    IUBMB Life; 2002 Jan; 53(1):3-14. PubMed ID: 12018405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphoproteomics and identification of substrates of protein tyrosine phosphatase dPTP61F in Drosophila S2 cells by mass spectrometry-based substrate trapping strategy.
    Chang YC; Lin SY; Liang SY; Pan KT; Chou CC; Chen CH; Liao CL; Khoo KH; Meng TC
    J Proteome Res; 2008 Mar; 7(3):1055-66. PubMed ID: 18281928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of protein tyrosine phosphatases: next-generation drugs?
    Bialy L; Waldmann H
    Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.
    Szedlacsek SE; Aricescu AR; Fulga TA; Renault L; Scheidig AJ
    J Mol Biol; 2001 Aug; 311(3):557-68. PubMed ID: 11493009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of oncogenic protein tyrosine phosphatases in cancer.
    Hardy S; Julien SG; Tremblay ML
    Anticancer Agents Med Chem; 2012 Jan; 12(1):4-18. PubMed ID: 21707506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
    Bishop AC; Zhang XY; Lone AM
    Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.
    Frankson R; Yu ZH; Bai Y; Li Q; Zhang RY; Zhang ZY
    Cancer Res; 2017 Nov; 77(21):5701-5705. PubMed ID: 28855209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.